Lobeglitazone Sulfate 0.5mg Tablets

Lobeglitazone Sulfate 0.5mg is an insulin-sensitising medicine for type 2 diabetes. It helps the body respond more effectively to its own insulin and may be used when improved glucose control is needed alongside diet, activity and other diabetes treatment.
Swallow the tablet once daily with water, with or without food, at a consistent time. Track glucose readings and changes in weight or ankle swelling during treatment.
Lobeglitazone activates PPAR-gamma receptors involved in glucose and fat metabolism. This increases insulin sensitivity in tissues such as muscle and fat.
Weight gain, fluid retention, headache and upper respiratory symptoms may occur. Breathlessness, rapid weight gain or increasing leg swelling can indicate fluid overload.
Heart failure and liver disease are important before starting treatment. Fluid retention can worsen with insulin. Fracture risk and episodes of low glucose with insulin or sulfonylureas also need consideration.
Improved insulin sensitivity can help lower glucose without relying solely on increasing insulin release from the pancreas.
No. Its effect develops over time through changes in insulin sensitivity; it is not a treatment for diabetic ketoacidosis or acute severe hyperglycaemia.
Weight gain can reflect increased fat mass or retained fluid. A rapid increase with swelling or breathlessness needs prompt assessment.
Some regimens combine them, but fluid retention and hypoglycaemia become more important. Insulin requirements may change as sensitivity improves.
No. It supports glucose control within an overall diabetes plan; blood pressure, lipids, kidney health and foot care remain separate needs.
It is not a substitute for the insulin that is missing in type 1 diabetes.
Insulin sensitivity: how effectively tissues respond to insulin. PPAR-gamma: a receptor regulating glucose and fat metabolism. Oedema: swelling caused by retained fluid. Glycaemic control: management of blood glucose levels.; AR: Lobeglitazone Sulfate 0.5mg أقراص; FR: Lobeglitazone Sulfate 0.5mg comprimés; PT: Lobeglitazone Sulfate 0.5mg comprimidos; ES: Lobeglitazone Sulfate 0.5mg comprimidos; RU: Lobeglitazone Sulfate 0.5mg таблетки; ID: Lobeglitazone Sulfate 0.5mg tablet; VI: Lobeglitazone Sulfate 0.5mg viên nén; MS: Lobeglitazone Sulfate 0.5mg tablet; TL: Lobeglitazone Sulfate 0.5mg mga tableta; ZH-SG: Lobeglitazone Sulfate 0.5mg 片剂
International B2B Enquiry
Send a structured B2B enquiry for Lobeglitazone Sulfate 0.5mg Tablets under Diabetes Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Lobeglitazone Sulfate 0.5mg Tablets